Patents-Review.com
ClassID:

20120 ⎘

A61K9/2806 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Dragees; Coated pills or tablets, e.g. with film or compression coating Coating materials

Sub-classes:
Recent Application in this class:
#1
20260097032
2026-04-09

PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF

 #2
20260027075
2026-01-29

SOLID DOSAGE FORMS OF ELAFIBRANOR

 #3
20260021083
2026-01-22

IRAK4 INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF

 #4
20250213488
2025-07-03

SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

 #5
20250213487
2025-07-03

SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

 #6
20250205202
2025-06-26

MAGNESIUM BIOTINATE COMPOSITIONS AND METHODS OF USE

 #7
20250073203
2025-03-06

IMMUNOSUPPRESSANT FORMULATION

 #8
20240415936
2024-12-19

FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS

 #9
20240408023
2024-12-12

DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES

 #10
20240366512
2024-11-07

Synthetic progestogens and pharmaceutical compositions comprising the same

 #11
20240299364
2024-09-12

Magnesium biotinate compositions and methods of use

 #12
20240226103
2024-07-11

SOLID DISPERSION OF A HER2 INHIBITOR

 #13
20240000733
2024-01-04

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

 #14
20230372248
2023-11-23

Synthetic progestogens and pharmaceutical compositions comprising the same

 #15
20230046871
2023-02-16

Synthetic progestogens and pharmaceutical compositions comprising the same

 #16
20220339107
2022-10-27

Synthetic progestogens and pharmaceutical compositions comprising the same

 #17
20220339106
2022-10-27

Synthetic progestogens and pharmaceutical compositions comprising the same

 #18
20220241209
2022-08-04

Synthetic progestogens and pharmaceutical compositions comprising the same

 #19
20220218615
2022-07-14

Synthetic progestogens and pharmaceutical compositions comprising the same

 #20
20220192991
2022-06-23

Synthetic progestogens and pharmaceutical compositions comprising the same

 #21
20220183984
2022-06-16

Synthetic progestogens and pharmaceutical compositions comprising the same

 #22
20220151957
2022-05-19

Biguanide compositions and methods of treating metabolic disorders

 #23
20220110908
2022-04-14

Low-Dose Doxepin Formulations And Methods Of Making And Using The Same

 #24
20220040113
2022-02-10

Synthetic progestogens and pharmaceutical compositions comprising the same

 #25
20210299146
2021-09-30

Synthetic progestogens and pharmaceutical compositions comprising the same

 #26
20210213035
2021-07-15

Synthetic progestogens and pharmaceutical compositions comprising the same

 #27
20210177765
2021-06-17

Core tablet composite preparation comprising mosapride and rabeprazole

 #28
20210161860
2021-06-03

IMMUNOSUPPRESSANT FORMULATION

 #29
20210128586
2021-05-06

METHODS OF SIZING 6B,7B:15B,16B-DIMETHYLENE-3-OXO-17A-PREGN-4-ENE-21,17-CARBOLACTONE PARTICLES AND COMPOSITIONS COMPRISING THE SAME

 #30
20210128479
2021-05-06

Dosage forms of controlled release at specific gastrointestinal sites

 #31
20210100776
2021-04-08

Magnesium biotinate compositions and methods of use

 #32
20210008068
2021-01-14

Solid dosage forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate

 #33
20200352864
2020-11-12

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION

 #34
20200170991
2020-06-04

Low-dose doxepin formulations and methods of making and using the same

 #35
20200138751
2020-05-07

Biguanide compositions and methods of treating metabolic disorders

 #36
20200138720
2020-05-07

Pharmaceutical formulation containing gelling agent

 #37
20200113842
2020-04-16

Tablet

 #38
20190328705
2019-10-31

IMMUNOSUPPRESSANT FORMULATION

 #39
20190209657
2019-07-11

Formulations for oral administration of active agents

 #40
20190201346
2019-07-04

Controlled release and taste masking oral pharmaceutical composition

 #41
20190134061
2019-05-09

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #42
20190117580
2019-04-25

Pharmaceutical formulation containing gelling agent

 #43
20190110996
2019-04-18

Pharmaceutical Formulation Containing Gelling Agent

 #44
20190076380
2019-03-14

Biguanide compositions and methods of treating metabolic disorders

 #45
20190070119
2019-03-07

Pharmaceutical formulation containing gelling agent

 #46
20190046453
2019-02-14

Controlled release and taste masking oral pharmaceutical composition

 #47
20190022112
2019-01-24

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #48
20190015428
2019-01-17

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITIONS

 #49
20190015342
2019-01-17

Controlled release and taste masking oral pharmaceutical composition

 #50
20190015341
2019-01-17

Pharmaceutical Formulation Containing Gelling Agent

 #51
20190000843
2019-01-03

SOLID DOSAGE FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOATE

 #52
20180325870
2018-11-15

Compounds as opioid receptor modulators

 #53
20180325827
2018-11-15

Delivery system comprising a core and a digestible polymer shell

 #54
20180318225
2018-11-08

Controlled release and taste masking oral pharmaceutical composition

 #55
20180256533
2018-09-13

Low-dose doxepin formulations and methods of making and using the same

 #56
20180177731
2018-06-28

Composite preparation of mosapride and rabeprazole

 #57
20180147151
2018-05-31

Pharmaceutical Formulation Containing Gelling Agent

 #58
20180125788
2018-05-10

Pharmaceutical Formulation Containing Gelling Agent

 #59
20180071264
2018-03-15

Magnesium biotinate compositions and methods of use

 #60
20180055771
2018-03-01

Pharmaceutical formulation containing gelling agent

 #61
20180021262
2018-01-25

Pharmaceutical formulation containing gelling agent

 #62
20170354608
2017-12-14

Coating agent containing nano-SiOand a preparation method thereof

 #63
20170304323
2017-10-26

Controlled release and taste masking oral pharmaceutical compositions

 #64
20170304322
2017-10-26

Controlled release and taste masking oral pharmaceutical compositions

 #65
20170231917
2017-08-17

Delivery system comprising a core and a digestible polymer shell

 #66
20170209394
2017-07-27

Biguanide compositions and methods of treating metabolic disorders

 #67
20170157055
2017-06-08

PHARMACEUTICAL ABUSE DETERRENT COMPOSITION

 #68
20170112765
2017-04-27

Pharmaceutical formulation containing gelling agent

 #69
20170065525
2017-03-09

Pharmaceutical formulation containing gelling agent

 #70
20170020864
2017-01-26

Pharmaceutical formulation containing gelling agent

 #71
20170020863
2017-01-26

Pharmaceutical formulation containing gelling agent

 #72
20160256420
2016-09-08

Phosphate-binding magnesium salts and uses thereof

 #73
20160151499
2016-06-02

Pharmaceutical formulation containing gelling agent

 #74
20160151358
2016-06-02

Pharmaceutical formulation containing gelling agent

 #75
20160151357
2016-06-02

Pharmaceutical formulation containing gelling agent

 #76
20160151356
2016-06-02

Pharmaceutical formulation containing gelling agent

 #77
20160151355
2016-06-02

Pharmaceutical formulation containing gelling agent

 #78
20160151297
2016-06-02

Pharmaceutical formulation containing gelling agent

 #79
20160151289
2016-06-02

Pharmaceutical formulation containing gelling agent

 #80
20160151277
2016-06-02

Pharmaceutical formulation containing gelling agent

 #81
20160067237
2016-03-10

Sensory Stimulation for Cessation of Eating

 #82
20160060305
2016-03-03

Use of flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

 #83
20160045479
2016-02-18

Pharmaceutical composition for oral administration

 #84
20160030393
2016-02-04

Compounds as opioid receptor modulators

 #85
20160000723
2016-01-07

Pharmaceutical formulation containing gelling agent

 #86
20160000718
2016-01-07

Pharmaceutical Formulation Containing Gelling Agent

 #87
20150374628
2015-12-31

Pharmaceutical formulation containing gelling agent

 #88
20150283250
2015-10-08

Pharmaceutical formulation containing gelling agent

 #89
20150265607
2015-09-24

Pharmaceutical formulation containing gelling agent

 #90
20150265602
2015-09-24

Pharmaceutical formulation containing gelling agent

 #91
20150238481
2015-08-27

Pharmaceutical formulation containing gelling agent

 #92
20150231084
2015-08-20

Osmotic floating tablets

 #93
20150182628
2015-07-02

Pharmaceutical formulation containing gelling agent

 #94
20150157632
2015-06-11

SOLID DOSAGE FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOATE

 #95
20150150837
2015-06-04

Composition and method for treatment of NASH

 #96
20150148319
2015-05-28

Pharmaceutical formulation containing gelling agent

 #97
20150086627
2015-03-26

DOSAGE FORMS OF HALOFUGINONE AND METHODS OF USE

 #98
20140322320
2014-10-30

NOVEL COMPOSITIONS FOR EMESIS CONTROL IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY AND METHODS THEREOF

 #99
20140248348
2014-09-04

Use of flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

 #100
20140227358
2014-08-14

ORGANIC COMPOUNDS

 #101
20140065216
2014-03-06

Bioactive Dose Having Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder

 #102
20140010877
2014-01-09

Phosphate-binding magnesium salts and uses thereof

 #103
20130259936
2013-10-03

Low-dose doxepin formulations and methods of making and using the same

 #104
20130245055
2013-09-19

Pharmaceutical formulation containing gelling agent

 #105
20130064924
2013-03-14

NUTRITIONAL SUPPLEMENT FOR USE UNDER PHYSIOLOGICALLY STRESSFUL CONDITIONS

 #106
20130053360
2013-02-28

CONTROLLED RELEASE AND TASTE MASKING ORAL PHARMACEUTICAL COMPOSITION

 #107
20130022679
2013-01-24

Controlled release and taste masking oral pharmaceutical composition

 #108
20120321710
2012-12-20

Controlled Release and Taste Masking Oral Pharmaceutical Composition

 #109
20120288559
2012-11-15

ORGANIC COMPOUNDS

 #110
20120282352
2012-11-08

PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF

 #111
20120220559
2012-08-30

Controlled Release and Taste Masking Oral Pharmaceutical Composition

 #112
20120213850
2012-08-23

Controlled release and taste masking oral pharmaceutical composition

 #113
20120195964
2012-08-02

Phosphate-binding magnesium salts and uses thereof

 #114
20120129769
2012-05-24

ORALLY ADMINISTERABLE PHARMACEUTICAL PREPARATION CONTAINING INSULIN

 #115
20120128733
2012-05-24

Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

 #116
20120108622
2012-05-03

Pharmaceutical formulation containing gelling agent

 #117
20120021053
2012-01-26

CONTROLLED RELEASE AND TASTE-MASKING ORAL PHARMACEUTICAL COMPOSITION

 #118
20120003306
2012-01-05

Pharmaceutical composition of nanoparticles for protein drug delivery

 #119
20110318391
2011-12-29

Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive

 #120
20110212176
2011-09-01

CICLOPIROX AND CYTARABINE FOR THE TREATMENT OF LEUKEMIC DISORDERS

 #121
20110077258
2011-03-31

Treatment of malaria

 #122
20110070287
2011-03-24

Film-Coated Compressed Chewing Gum

 #123
20110045063
2011-02-24

PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF

 #124
20100324051
2010-12-23

Compounds as opioid receptor modulators

 #125
20100239669
2010-09-23

Combinations of statins and anti-obesity agent

 #126
20100234443
2010-09-16

Combinations of statins and anti-obesity agent

 #127
20100168148
2010-07-01

Pharmaceutical formulation containing gelling agent

 #128
20100040678
2010-02-18

ORGANIC COMPOUNDS

 #129
20090269399
2009-10-29

Phosphate-binding magnesium salts and uses thereof

 #130
20090221789
2009-09-03

Crystalline polypeptides

 #131
20090081287
2009-03-26

Pharmaceutical composition containing gelling agent

 #132
20090074862
2009-03-19

LOW-DOSE DOXEPIN FORMULATIONS AND METHODS OF MAKING AND USING THE SAME

 #133
20090011010
2009-01-08

Controlled release and taste masking oral pharmaceutical composition

 #134
20080248115
2008-10-09

Combinations of statins and anti-obesity agent

 #135
20080226746
2008-09-18

Nutritional supplement for women

 #136
20080096888
2008-04-24

Compounds as opioid receptor modulators

 #137
20070249673
2007-10-25

Method for administering tolperisone

 #138
20070193502
2007-08-23

Method of producing fine particle-like materials, and fine particle-link materials

 #139
20070031487
2007-02-08

Nutritional supplement for women

 #140
20060159749
2006-07-20

Controlled release and taste masking oral pharmaceutical composition

 #141
20060134208
2006-06-22

Controlled release and taste masking oral pharmaceutical composition

 #142
20050203143
2005-09-15

Compounds as opioid receptor modulators